Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Demarest

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Child Neurology|December 24, 2014
Early-Onset Aicardi-Goutières Syndrome: Magnetic Resonance Imaging (MRI) Pattern RecognitionAdeline Vanderver, Morgan Prust, Nadja Kadom, et al.
Epilepsia|June 18, 2022
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progressJuliet K Knowles, Ingo Helbig, Cameron S Metcalf, et al.
Brain and Behavior|November 14, 2025
Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency DisorderPeter Jacoby, Eric D Marsh, Scott Demarest, et al.
Journal of Child Neurology|August 11, 2021
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency DisorderJacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, et al.
Nature Communications|November 12, 2024
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseasesOlivia Kim-McManus, Joseph G Gleeson, Laurence Mignon, et al.
Epilepsia|August 27, 2024
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorderJacinta M Saldaris, Peter Jacoby, Jenny Downs, et al.
Epilepsy Research|September 26, 2023
The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorderSonja I Ziniel, Alexandra Mackie, Jacinta Saldaris, et al.
Orphanet Journal of Rare Diseases|May 22, 2026
Paying for precision: funding approaches for N-of-1 trials of individualized gene targeted therapiesNicole Nolen, Annemieke Aartsma-Rus, Christine Caneva, et al.
Frontiers in Neurology|July 7, 2022
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency DisorderSam Amin, Marie Monaghan, Angel Aledo-Serrano, et al.
Pediatric Neurology|July 21, 2020
Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US ClinicsEmily de Los Reyes, Lenora Lehwald, Erika F Augustine, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Child Neurology|December 24, 2014
Early-Onset Aicardi-Goutières Syndrome: Magnetic Resonance Imaging (MRI) Pattern RecognitionAdeline Vanderver, Morgan Prust, Nadja Kadom, et al.
Epilepsia|June 18, 2022
Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progressJuliet K Knowles, Ingo Helbig, Cameron S Metcalf, et al.
Brain and Behavior|November 14, 2025
Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency DisorderPeter Jacoby, Eric D Marsh, Scott Demarest, et al.
Journal of Child Neurology|August 11, 2021
Content Validation of Clinician-Reported Items for a Severity Measure for CDKL5 Deficiency DisorderJacinta Saldaris, Judith Weisenberg, Elia Pestana-Knight, et al.
Nature Communications|November 12, 2024
A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseasesOlivia Kim-McManus, Joseph G Gleeson, Laurence Mignon, et al.
Epilepsia|August 27, 2024
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorderJacinta M Saldaris, Peter Jacoby, Jenny Downs, et al.
Epilepsy Research|September 26, 2023
The development, content and response process validation of a caregiver-reported severity measure for CDKL5 deficiency disorderSonja I Ziniel, Alexandra Mackie, Jacinta Saldaris, et al.
Orphanet Journal of Rare Diseases|May 22, 2026
Paying for precision: funding approaches for N-of-1 trials of individualized gene targeted therapiesNicole Nolen, Annemieke Aartsma-Rus, Christine Caneva, et al.
Frontiers in Neurology|July 7, 2022
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency DisorderSam Amin, Marie Monaghan, Angel Aledo-Serrano, et al.
Pediatric Neurology|July 21, 2020
Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US ClinicsEmily de Los Reyes, Lenora Lehwald, Erika F Augustine, et al.
Pageof 7